Collegium Pharmaceutical, Inc.
COLL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $170 | $117 | $96 | $71 |
| Short-Term Investments | $136 | $105 | $102 | $92 |
| Receivables | $234 | $213 | $229 | $229 |
| Inventory | $38 | $38 | $37 | $36 |
| Other Curr. Assets | $36 | $76 | $64 | $55 |
| Total Curr. Assets | $614 | $549 | $528 | $482 |
| Property Plant & Equip (Net) | $17 | $18 | $19 | $20 |
| Goodwill | $146 | $148 | $151 | $162 |
| Intangibles | $725 | $780 | $836 | $891 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $102 | $92 | $92 | $98 |
| Other NC Assets | $2 | $5 | $6 | $9 |
| Total NC Assets | $993 | $1,043 | $1,104 | $1,181 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,607 | $1,593 | $1,631 | $1,664 |
| Liabilities | – | – | – | – |
| Payables | $8 | $11 | $18 | $4 |
| Short-Term Debt | $66 | $66 | $66 | $66 |
| Tax Payable | $0 | $9 | $17 | $15 |
| Deferred Revenue | $1 | $0 | $10 | $10 |
| Other Curr. Liab. | $379 | $379 | $376 | $415 |
| Total Curr. Liab. | $453 | $465 | $487 | $510 |
| LT Debt | $870 | $763 | $778 | $793 |
| Deferred Rev, NC | $9 | $10 | $10 | $10 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $123 | $122 | $122 |
| Total NC Liab. | $880 | $896 | $910 | $925 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $6 | $7 | $7 |
| Total Liabilities | $1,333 | $1,360 | $1,397 | $1,435 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$118 | -$150 | -$162 | -$164 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $393 | $381 | $396 | $393 |
| Total Equity | $275 | $232 | $234 | $229 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,607 | $1,593 | $1,631 | $1,664 |
| Net Debt | $766 | $712 | $748 | $789 |